Published in Pharmacogenomics J on January 01, 2002
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.27
Infliximab for the treatment of active scleritis. Can J Ophthalmol (2009) 1.00
Predicting response to Anti-TNF Agents for the treatment of crohn's disease. Therap Adv Gastroenterol (2009) 0.96
Role of genetics in prediction of disease course and response to therapy. World J Gastroenterol (2010) 0.94
Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases. J Immunol Res (2015) 0.93
A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis. Ann Rheum Dis (2007) 0.91
Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol (2006) 0.90
Association of TNF and FcγRΙΙΙA gene polymorphisms with differential response to infliximab in a Greek cohort of Crohn's disease patients. Ann Gastroenterol (2011) 0.85
Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis. Eur J Clin Pharmacol (2012) 0.82
Genetics of inflammatory bowel disease: current status and future directions. Can J Gastroenterol (2006) 0.82
How does genotype influence disease phenotype in inflammatory bowel disease? Inflamm Bowel Dis (2013) 0.81
The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol (2012) 0.79
Current stage in inflammatory bowel disease: What is next? World J Gastroenterol (2015) 0.78
Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn's disease. World J Gastroenterol (2014) 0.76
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease. Therap Adv Gastroenterol (2016) 0.76
Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region. World J Gastroenterol (2014) 0.76
Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. Biomed Res Int (2015) 0.76
Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases. Aliment Pharmacol Ther (2016) 0.76
Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease. Am J Gastroenterol (2016) 0.75
Clinical and genetic factors predicting response to therapy in patients with Crohn's disease. United European Gastroenterol J (2014) 0.75
Can We Predict the Efficacy of Anti-TNF-α Agents? Int J Mol Sci (2017) 0.75
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
The human gene mutation database. Nucleic Acids Res (1998) 6.38
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol (1993) 4.68
Activation of nuclear factor kappa B inflammatory bowel disease. Gut (1998) 4.14
The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J (2000) 3.64
Characteristics and frequency of germline mutations at microsatellite loci from the human Y chromosome, as revealed by direct observation in father/son pairs. Am J Hum Genet (2000) 3.59
Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet (1989) 3.27
DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures. Forensic Sci Int (2006) 3.20
Evaluation of Y-chromosomal STRs: a multicenter study. Int J Legal Med (1997) 3.19
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80
The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet (1990) 2.59
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut (1996) 2.41
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet (1999) 2.29
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet (1997) 2.05
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
Use of X-linked markers for forensic purposes. Int J Legal Med (2003) 1.91
Chromosome Y microsatellites: population genetic and evolutionary aspects. Int J Legal Med (1997) 1.89
Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry (2009) 1.89
Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun (2004) 1.89
Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology (1998) 1.86
Analysis of molecular variance (AMOVA) of Y-chromosome-specific microsatellites in two closely related human populations. Hum Mol Genet (1996) 1.84
Postural dependency of the cerebral venous outflow. Lancet (2000) 1.81
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol (2006) 1.78
Human gene cloning: the storm before the lull? Nature (1986) 1.78
Drainage of esophageal leakage using endoscopic vacuum therapy: a prospective pilot study. Endoscopy (2010) 1.77
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut (2008) 1.75
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations. Am J Hum Genet (2001) 1.70
Predictors of PTSD in injured trauma survivors: a prospective study. Am J Psychiatry (1996) 1.68
Online reference database of European Y-chromosomal short tandem repeat (STR) haplotypes. Forensic Sci Int (2001) 1.67
Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta (2005) 1.66
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics (2001) 1.61
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61
Paternal relatedness and age proximity regulate social relationships among adult female rhesus macaques. Proc Natl Acad Sci U S A (2001) 1.61
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J (2010) 1.55
Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest (1993) 1.50
Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet (1997) 1.49
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol (1998) 1.49
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis. Aliment Pharmacol Ther (1998) 1.47
Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis. Scand J Gastroenterol (2001) 1.47
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene (2001) 1.46
Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet (1999) 1.45
Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol (2003) 1.45
DNA-fingerprinting: a short note on mutation rates. Hum Genet (1991) 1.44
Mechanisms of insertional mutagenesis in human genes causing genetic disease. Hum Genet (1991) 1.44
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol (2002) 1.44
Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls. Aliment Pharmacol Ther (2014) 1.43
Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study. Aliment Pharmacol Ther (2014) 1.43
Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry (2011) 1.43
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut (2002) 1.41
Primary sclerosing cholangitis mimicking choledocal cyst type 1 in a young patient. Endoscopy (1999) 1.41
[Hepatosplenomegaly]. Internist (Berl) (1994) 1.40
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut (2002) 1.40
[Therapy of chronic pancreatitis]. Dtsch Med Wochenschr (1996) 1.39
Inferior subluxation of the humeral head: the drooping shoulder. Radiology (1971) 1.39
Sex difference in D7S8 marker allele distribution in adult cystic fibrosis patients. Lancet (1989) 1.39
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Haemost (1995) 1.36
A new method for the evaluation of matches in non-recombining genomes: application to Y-chromosomal short tandem repeat (STR) haplotypes in European males. Forensic Sci Int (2000) 1.35
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene (2009) 1.32
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut (2003) 1.31
Genetic association studies of bronchial asthma--a need for Bonferroni correction? Hum Genet (2000) 1.31
Genetic risk and recombination fraction--an example of non-monotonic dependency. Hum Genet (1987) 1.30
Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience (2003) 1.29
Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet (1998) 1.29
DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med (2001) 1.28
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene (2006) 1.27
Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun (2006) 1.26
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol (2000) 1.26